Provide a 10 pages analysis while answering the following question: Functioning of Biotechnology. Prepare this assignment according to the guidelines found in the APA Style Guide. An abstract is required. Gene therapy is offering that hope to individuals with genetic disorders that in the past, ensured certain and untimely death and suffering. In the 1970s, scientists began to grasp not only the relevance of the human genome but the possibilities of treating genetic disorders with “gene surgery”. The idea was to replace faulty genes with viable ones with aspirations of curing diseases. Originally, scientists took an approach that focused mainly on single genes. It was first assumed that this was not only the answer to many incurable diseases but possibly the best that science could do. The 1980s ushered in new advancements which allowed them to look at not only treating single-gene genetic disorders but also treating acquired diseases with gene therapy. Between then and now, research and technology have advanced gene therapy to new and unimaginable medical heights.
The term ’gene therapy’ is actually a relatively broad term and encompasses a myriad of different methods and procedures. The fundamental element of our genetic code is the bases (adenosine, thiamine, cytosine, and guanine) which are formed in specific sequences to provide the blueprints for proteins (this is essentially what a gene is). As we know, most genetic disorders involve either nonfunctional proteins, chromosomal additions, and deletions as well as gene abnormalities. The goal of gene therapy is to place functional genetic material into a cell in order to correct the abnormality. It should be noted that though gene therapy has come a long way, there is still a lot to be accomplished, as many genetic disorders remain untreatable.
One aspect of faulty genetics or genetic expression is genes that ‘turn on‘ or become activated at some point in a person‘s life span resulting in cancer or other diseases, “A common approach in gene therapy is to identify a malfunctioning gene and supply the patient with functioning copies of that gene (Mammen et al 2007)”.  .